Back
Perrigo Co PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
46
PRGO
Perrigo Co PLC
Last Price:
$28.06
Seasonality Move:
0.1%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
46
Perrigo Co PLC (PRGO)
is a Sell
Is Perrigo Co PLC a Buy, Sell or Hold?
-
The current Perrigo Co PLC [PRGO] share price is $28.06. The Score for PRGO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
PRGO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRGO Stock Price Chart
What is Perrigo Co PLC's stock price today?
-
The Perrigo Co PLC share price today is $28.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRGO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
PRGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 56.73 | Buy |
| Chaikin Money Flow: | 1268491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.04 - 28.84) | Buy |
| Bollinger Bands (100): | (24.75 - 27.89) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.41 | Buy |
| Relative Strength Index (14 RSI): | 55.64 | Buy |
| Chaikin Money Flow: | 78938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.82 - 268.04) | Buy |
| Bollinger Bands (100): | (240.65 - 270.25) | Buy |
PRGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.8 | Buy |
| 20-day SMA: | 28.06 | Sell |
| 50-day SMA: | 25.99 | Buy |
| 200-day SMA: | 26.59 | Buy |
| 8-day EMA: | 27.76 | Buy |
| 20-day EMA: | 27.46 | Buy |
| 50-day EMA: | 26.71 | Buy |
| 200-day EMA: | 27.11 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 271.33 | Sell |
| 20-day SMA: | 255.41 | Buy |
| 50-day SMA: | 259.88 | Buy |
| 200-day SMA: | 253.94 | Buy |
| 8-day EMA: | 268.64 | Sell |
| 20-day EMA: | 261.32 | Buy |
| 50-day EMA: | 257.88 | Buy |
| 200-day EMA: | 244.57 | Buy |
Perrigo Co PLC Earnings Growth & PRGO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.41 per share, and an increase next year of $0.19 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Perrigo Co PLC Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||